An Observational Study of Risk Factors and Long-term Prognosis of Patients With Liver Abscess in the "Real-world"
An Observational Study of Risk Factors and Long-term Prognosis of Patients With Pyogenic Liver Abscess in the "Real-world"
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Xuyen Xu, MD
- Phone Number: 020-62786539
- Email: xuxuwen95@126.com
Study Contact Backup
- Name: Muye Xia, MD
- Phone Number: +86 17665730806
- Email: xiamuye@foxmail.com
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 5100515
- Recruiting
- Nanfang Hospital of Southern Medical University
-
Contact:
- Xuyen M University, MD
- Phone Number: 02062786539
- Email: xuxuwen95@126.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients older than 18 years of age;
- Irrespective of gender;
- Symptomatic patients of liver abscess confirmed with radiology imaging, either by ultrasonography or computed tomography scan.
Exclusion Criteria:
- Patients <18 years old;
- Pregnancy at presentation.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion and causes of deaths within 2 years of discharge from hospital
Time Frame: 2 years
|
Define the proportion and causes of deaths within 2 years of discharge from hospital for patients admitted to the Department for pyogenic liver abscesses.
|
2 years
|
|
Proportion and causes of re-hospitalization within 2 years of discharge from hospital
Time Frame: 2 years
|
Define the proportion and causes of re-hospitalization within 2 years of discharge from hospital for patients admitted to the Department for pyogenic liver abscesses.
|
2 years
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The recurrence rate of pyogenic liver abscess
Time Frame: 2 years
|
Development new liver abscess after clinical cure during the 2 years follow up period
|
2 years
|
|
The number of participants with Histological Change in the Liver
Time Frame: 2 years
|
Assessment of histological change in the liver by using ultrasonography or transient elastography during the 2 years follow up period
|
2 years
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- NFEC-2021-355
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.